Prognostic nutritional index as a predictor of prognosis in patients with diffuse large B cell lymphoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic nutritional index as a predictor of prognosis in patients with diffuse large B cell lymphoma
Authors
Keywords
Lymphoma, large B-cell, diffuse, Prognostic nutritional index, Prognostic marker, Prognosis
Journal
WIENER KLINISCHE WOCHENSCHRIFT
Volume 129, Issue 11-12, Pages 411-419
Publisher
Springer Nature
Online
2016-09-08
DOI
10.1007/s00508-016-1077-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYCtranslocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma
- (2016) Keisuke Kawamoto et al. CANCER SCIENCE
- The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type
- (2015) Kai-Lin Chen et al. ANNALS OF HEMATOLOGY
- The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study
- (2015) Elena Raffetti et al. Journal of Translational Medicine
- p53 Expression Is a Strong Marker of Inferior Survival in De Novo Diffuse Large B-Cell Lymphoma and May Have Enhanced Negative Effect With MYC Coexpression
- (2014) Yi Xie et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era
- (2014) Samir Dalia et al. ANNALS OF HEMATOLOGY
- The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
- (2014) Kaiyu Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- C-MYC Aberrations as Prognostic Factors in Diffuse Large B-cell Lymphoma: A Meta-Analysis of Epidemiological Studies
- (2014) Kuangguo Zhou et al. PLoS One
- The Prognostic Impact of Absolute Lymphocyte and Monocyte Counts at Diagnosis of Diffuse Large B-Cell Lymphoma in the Rituximab Era
- (2013) Kazunari Aoki et al. ACTA HAEMATOLOGICA
- Evaluation of BCL-6, CD10, CD138 and MUM-1 Expression in Diffuse Large B-Cell Lymphoma patients: CD138 is a Marker of Poor Prognosis
- (2013) Khaldon Bodoor et al. Asian Pacific Journal of Cancer Prevention
- A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)
- (2012) D J Pinato et al. BRITISH JOURNAL OF CANCER
- Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
- (2011) Digant Gupta et al. Nutrition Journal
- Nutritional predictors of postoperative outcome in pancreatic cancer
- (2010) M. Kanda et al. BRITISH JOURNAL OF SURGERY
- Prognostic nutritional Index: A tool to predict the biological aggressiveness of gastric carcinoma
- (2010) Tadahiro Nozoe et al. SURGERY TODAY
- Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
- (2009) Isabelle Ray-Coquard et al. CANCER RESEARCH
- Systemic inflammation, nutritional status and survival in patients with cancer
- (2009) Donald C McMillan CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma
- (2008) Luis F. Porrata et al. AMERICAN JOURNAL OF HEMATOLOGY
- Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients’ survival benefit from rituximab
- (2008) Yasuhiro Oki et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started